{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T23:01:09Z","timestamp":1785020469265,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Innovation Fund of CAMS & PUMC","award":["NO. 1012014X06"],"award-info":[{"award-number":["NO. 1012014X06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00280-016-3030-x","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T09:47:33Z","timestamp":1460627253000},"page":"1087-1096","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The anti-angiogenic effect of dexamethasone in a murine hepatocellular carcinoma model by augmentation of gluconeogenesis pathway in malignant cells"],"prefix":"10.1007","volume":"77","author":[{"given":"Fei","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"3030_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","volume":"29","author":"F Judah","year":"2002","unstructured":"Judah F (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15\u201318. doi: 10.1053\/sonc.2002.37263","journal-title":"Semin Oncol"},{"key":"3030_CR2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","volume":"8","author":"AX Zhu","year":"2011","unstructured":"Zhu AX, Duda DG, Sahani DV, Jain RK (2011) HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol 8:292\u2013301. doi: 10.1038\/nrclinonc.2011.30","journal-title":"Nat Rev Clin Oncol"},{"key":"3030_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1101\/cshperspect.a006502","volume":"2","author":"S Koch","year":"2012","unstructured":"Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2:369\u2013375. doi: 10.1101\/cshperspect.a006502","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3030_CR4","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-06-1520","volume":"12","author":"M Kowanetz","year":"2006","unstructured":"Kowanetz M, Ferrara N (2006) Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 12:5018\u20135022. doi: 10.1158\/1078-0432.CCR-06-1520","journal-title":"Clin Cancer Res"},{"key":"3030_CR5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9440(10)64525-7","volume":"157","author":"K Spilsbury","year":"2000","unstructured":"Spilsbury K, Garrett KL, Shen W-Y, Constable IJ, Rakoczy PE (2000) overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157:135\u2013144. doi: 10.1016\/s0002-9440(10)64525-7","journal-title":"Am J Pathol"},{"key":"3030_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3346\/jkms.2006.21.2.272","volume":"21","author":"M Woo Sung","year":"2006","unstructured":"Woo Sung M, Ho Sung P, Ki Hoon Y, Kyu Yun J, Myoung Jae K, Harry P, Tarnawski AS (2006) expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis. J Korean Med Sci 21:272\u2013278","journal-title":"J Korean Med Sci"},{"key":"3030_CR7","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"RA Santos","year":"2003","unstructured":"Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T (2003) Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor mas. Proc Natl Acad Sci 100:8258\u20138263","journal-title":"Proc Natl Acad Sci"},{"key":"3030_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1371\/annotation\/9e189146-9c58-44d0-8bff-347bde7018e9","volume":"8","author":"S Zhou","year":"2013","unstructured":"Zhou S, Yang Y, Yang Y, Tao H, Li D, Zhang J, Jiang G, Fang J (2013) Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model. PLoS One 8:211\u2013236. doi: 10.1371\/journal.pone.0068589","journal-title":"PLoS One"},{"key":"3030_CR9","author":"KE Craven","year":"2015","unstructured":"Craven KE, Gore J, Korc M (2015) Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma. Cancer Lett. doi: 10.1016\/j.canlet.2015.11.047","journal-title":"Cancer Lett"},{"key":"3030_CR10","first-page":"123","volume":"68","author":"L Yan","year":"2014","unstructured":"Yan L, Bi T, Shen G, Li Z, Wu G, Zheng W, Qian L, Gao Q (2014) Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR\/MMP-9 signaling pathway. Cytotechnology 68:123\u2013133. doi: 10.1007\/s10616-014-9763-7","journal-title":"Cytotechnology"},{"key":"3030_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.124.3215.267","volume":"124","author":"S Weinhouse","year":"1956","unstructured":"Weinhouse S, Warburg O, Burk D, Schade AL (1956) On respiratory impairment in cancer cells. Science 124:267\u2013272","journal-title":"Science"},{"key":"3030_CR12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jhep.2011.01.038","volume":"55","author":"K Koji","year":"2011","unstructured":"Koji K, Etsuro H, Tatsuya H, Masato N, Satoru S, Yuji N, Kenya Y, Hiromitsu N, Kojiro T, Kentaro Y (2011) Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J Hepatol 55:846\u2013857. doi: 10.1016\/j.jhep.2011.01.038","journal-title":"J Hepatol"},{"key":"3030_CR13","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/ncomms3508","volume":"4","author":"R Ma","year":"2013","unstructured":"Ma R, Zhang W, Tang K, Zhang H, Zhang Y, Li D, Li Y, Xu P, Luo S, Cai W, Ji T, Katirai F, Ye D, Huang B (2013) Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat Commun 4:2508\u20132520. doi: 10.1038\/ncomms3508","journal-title":"Nat Commun"},{"key":"3030_CR14","doi-asserted-by":"crossref","first-page":"e1872","DOI":"10.1038\/cddis.2015.245","volume":"6","author":"MW Khan","year":"2015","unstructured":"Khan MW, Chakrabarti P (2015) Gluconeogenesis combats cancer: opening new doors in cancer biology. Cell Death Dis 6:e1872. doi: 10.1038\/cddis.2015.245","journal-title":"Cell Death Dis"},{"key":"3030_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-079X.2011.00882.x","volume":"51","author":"X Yuan","year":"2011","unstructured":"Yuan X, Li B, Li H (2011) Xiu R (2011) Melatonin inhibits IL-1beta-induced monolayer permeability of human umbilical vein endothelial cells via Rac activation. J Pineal Res 51:220\u2013225. doi: 10.1111\/j.1600-079X.2011.00882.x","journal-title":"J Pineal Res"},{"key":"3030_CR16","doi-asserted-by":"crossref","first-page":"e0130341","DOI":"10.1371\/journal.pone.0130341","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Yang C, Gu Q, Sims M, Gu W, Pfeffer LM, Yue J (2015) KLF4 promotes angiogenesis by activating VEGF signaling in human retinal microvascular endothelial cells. PLoS One 10:e0130341. doi: 10.1371\/journal.pone.0130341","journal-title":"PLoS One"},{"key":"3030_CR17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","volume":"25","author":"JW Tomlinson","year":"2004","unstructured":"Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831\u2013866. doi: 10.1210\/er.2003-0031","journal-title":"Endocr Rev"},{"key":"3030_CR18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db07-0381","volume":"57","author":"KY Deuk","year":"2008","unstructured":"Deuk KY, Keun-Gyu P, Yong-Soo L, Yun-Yong P, Don-Kyu K, Balachandar N, Won GuJ, Won-Jea C, Joohun H, In-Kyu L (2008) Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57:306\u2013314","journal-title":"Diabetes"},{"key":"3030_CR19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1469-7580.2012.01481.x","volume":"220","author":"GH Gladstones","year":"2012","unstructured":"Gladstones GH, Burton PJ, Mark PJ, Waddell BJ, Roberts P (2012) Immunolocalisation of 11beta-HSD-1 and -2, glucocorticoid receptor, mineralocorticoid receptor and Na+\u00a0K+\u00a0-ATPase during the postnatal development of the rat epididymis. J Anat 220:350\u2013362. doi: 10.1111\/j.1469-7580.2012.01481.x","journal-title":"J Anat"},{"key":"3030_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.phymed.2012.12.020","volume":"20","author":"CG Mohan","year":"2013","unstructured":"Mohan CG, Viswanatha GL, Savinay G, Rajendra CE, Halemani PD (2013) 1,2,3,4,6 Penta-O- galloyl-beta-d-glucose, a bioactivity guided isolated compound from Mangifera indica inhibits 11beta-HSD-1 and ameliorates high fat diet-induced diabetes in C57BL\/6 mice. Phytomedicine 20:417\u2013426. doi: 10.1016\/j.phymed.2012.12.020","journal-title":"Phytomedicine"},{"key":"3030_CR21","first-page":"XE01","volume":"9","author":"L Yadav","year":"2015","unstructured":"Yadav L, Puri N, Rastogi V, Satpute P, Sharma V (2015) Tumour angiogenesis and angiogenic inhibitors: a review. J Clin Diagn Res 9:XE01\u2013XE05. doi: 10.7860\/JCDR\/2015\/12016.6135","journal-title":"J Clin Diagn Res"},{"key":"3030_CR22","first-page":"165","volume":"13","author":"C Guillaume","year":"2013","unstructured":"Guillaume C, Nathalie LF, Magdalena T, Bouchra HR, Jacek S, Alan G, Alexandra FC, Krzysztof K, St\u00e9phane P, Agata M (2013) Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth. Mol Cancer Ther 13:165\u2013178. doi: 10.1158\/1535-7163.MCT-13-0637","journal-title":"Mol Cancer Ther"},{"key":"3030_CR23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417\u2013427. doi: 10.1038\/nrd3455","journal-title":"Nat Rev Drug Discov"},{"key":"3030_CR24","doi-asserted-by":"crossref","first-page":"e95912","DOI":"10.1371\/journal.pone.0095912","volume":"9","author":"FZ Li Li","year":"2014","unstructured":"Li Li FZ, Juan Lu, Li Tingting, Yang Hong, Chunhui Wu, Liu Yiyao (2014) Notch-1 signaling promotes the malignant features of human breast cancer through NF-kB activation. PLoS One 9:e95912. doi: 10.1371\/journal.pone.0095912.g001","journal-title":"PLoS One"},{"key":"3030_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2012.11.015","volume":"330","author":"M Kang","year":"2013","unstructured":"Kang M, Jiang B, Xu B, Lu W, Guo Q, Xie Q, Zhang B, Dong X, Chen D, Wu Y (2013) Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer. Cancer Lett 330:11\u201321. doi: 10.1016\/j.canlet.2012.11.015","journal-title":"Cancer Lett"},{"key":"3030_CR26","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/onc.2011.467","volume":"31","author":"XY Ding","year":"2012","unstructured":"Ding XY, Ding J, Wu K, Wen W, Liu C, Yan HX, Chen C, Wang S, Tang H, Gao CK, Guo LN, Cao D, Li Z, Feng GS, Wang HY, Xu ZF (2012) Cross-talk between endothelial cells and tumor via delta-like ligand 4\/Notch\/PTEN signaling inhibits lung cancer growth. Oncogene 31:2899\u20132906. doi: 10.1038\/onc.2011.467","journal-title":"Oncogene"},{"key":"3030_CR27","doi-asserted-by":"crossref","first-page":"e70459","DOI":"10.1371\/journal.pone.0070459","volume":"8","author":"AV Benest","year":"2013","unstructured":"Benest AV, Kruse K, Savant S, Thomas M, Laib AM, Loos EK, Fiedler U, Augustin HG (2013) Angiopoietin-2 is critical for cytokine-induced vascular leakage. PLoS One 8:e70459. doi: 10.1371\/journal.pone.0070459","journal-title":"PLoS One"},{"key":"3030_CR28","doi-asserted-by":"crossref","first-page":"45643","DOI":"10.1074\/jbc.M404097200","volume":"279","author":"HD Skinner","year":"2004","unstructured":"Skinner HD, Zheng JZ, Fang J, Agani F, Jiang BH (2004) Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase\/AKT signaling. J Biol Chem 279:45643\u201345651. doi: 10.1074\/jbc.M404097200","journal-title":"J Biol Chem"},{"key":"3030_CR29","first-page":"1167","volume":"6","author":"E Callegari","year":"2013","unstructured":"Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M (2013) Role of microRNAs in hepatocellular carcinoma: a clinical perspective. Onco Targets Ther 6:1167\u20131178. doi: 10.2147\/ott.s36161","journal-title":"Onco Targets Ther"},{"key":"3030_CR30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2119\/molmed.2015.00022","volume":"21","author":"Y Liu","year":"2015","unstructured":"Liu Y, Li B, Wang X, Li G, Shang R, Yang J, Wang J, Zhang M, Chen Y, Zhang Y, Zhang C, Hao P (2015) Angiotensin-(1-7) suppresses hepatocellular carcinoma growth and angiogenesis via complex interactions of angiotensin II type 1 receptor, angiotensin II type 2 receptor and mas receptor. Mol Med 21:626\u2013636. doi: 10.2119\/molmed.2015.00022","journal-title":"Mol Med"},{"key":"3030_CR31","doi-asserted-by":"crossref","first-page":"e85002","DOI":"10.1371\/journal.pone.0085002","volume":"9","author":"PP Hao","year":"2014","unstructured":"Hao PP, Liu YP, Yang CY, Liang T, Zhang C, Song J, Han JK, Hou GH (2014) Evaluation of (131) I-anti-angiotensin II type 1 receptor monoclonal antibody as a reporter for hepatocellular carcinoma. PLoS One 9:e85002. doi: 10.1371\/journal.pone.0085002","journal-title":"PLoS One"},{"key":"3030_CR32","doi-asserted-by":"crossref","first-page":"e93264","DOI":"10.1371\/journal.pone.0093264","volume":"9","author":"Z Fan","year":"2014","unstructured":"Fan Z, Sehm T, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan NE (2014) Dexamethasone alleviates tumor-associated brain damage and angiogenesis. PLoS One 9:e93264. doi: 10.1371\/journal.pone.0093264","journal-title":"PLoS One"},{"key":"3030_CR33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1750-3639.2008.00139.x","volume":"18","author":"J Villeneuve","year":"2008","unstructured":"Villeneuve J, Galarneau H, Beaudet MJ, Tremblay P, Chernomoretz A, Vallieres L (2008) Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment. Brain Pathol 18:401\u2013414. doi: 10.1111\/j.1750-3639.2008.00139.x","journal-title":"Brain Pathol"},{"key":"3030_CR34","doi-asserted-by":"crossref","first-page":"35035","DOI":"10.1074\/jbc.M707557200","volume":"282","author":"P Yu","year":"2007","unstructured":"Yu P, Kodadek T (2007) Dynamics of the hypoxia-inducible factor-1-vascular endothelial growth factor promoter complex. J Biol Chem 282:35035\u201335045. doi: 10.1074\/jbc.M707557200","journal-title":"J Biol Chem"},{"key":"3030_CR35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.exer.2006.01.016","volume":"83","author":"O Arjamaa","year":"2006","unstructured":"Arjamaa O, Nikinmaa M (2006) Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res 83:473\u2013483. doi: 10.1016\/j.exer.2006.01.016","journal-title":"Exp Eye Res"},{"key":"3030_CR36","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/cddiscovery.2015.16","volume":"1","author":"MW Khan","year":"2015","unstructured":"Khan MW, Biswas D, Ghosh M, Mandloi S, Chakrabarti S, Chakrabarti P (2015) mTORC2 controls cancer cell survival by modulating gluconeogenesis. Cell Death Discov 1:15016. doi: 10.1038\/cddiscovery.2015.16","journal-title":"Cell Death Discov"},{"key":"3030_CR37","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1038\/onc.2012.6","volume":"31","author":"JW Clendening","year":"2012","unstructured":"Clendening JW, Penn LZ (2012) Targeting tumor cell metabolism with statins. Oncogene 31:4967\u20134978. doi: 10.1038\/onc.2012.6","journal-title":"Oncogene"},{"key":"3030_CR38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nm.2870","volume":"18","author":"K Birsoy","year":"2012","unstructured":"Birsoy K, Sabatini DM, Possemato R (2012) Untuning the tumor metabolic machine: targeting cancer metabolism: a bedside lesson. Nat Med 18:1022\u20131023. doi: 10.1038\/nm.2870","journal-title":"Nat Med"},{"key":"3030_CR39","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","volume":"18","author":"TW Meijer","year":"2012","unstructured":"Meijer TW, Kaanders JH, Span PN, Bussink J (2012) Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res 18:5585\u20135594. doi: 10.1158\/1078-0432.ccr-12-0858","journal-title":"Clin Cancer Res"},{"key":"3030_CR40","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1634\/theoncologist.2014-0260","volume":"21","author":"S Yennurajalingam","year":"2016","unstructured":"Yennurajalingam S, Williams JL, Chisholm G, Bruera E (2016) Effects of dexamethasone and placebo on symptom clusters in advanced cancer patients: a preliminary report. Oncologist 21:384\u2013390. doi: 10.1634\/theoncologist.2014-0260","journal-title":"Oncologist"},{"key":"3030_CR41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.biomaterials.2014.10.030","volume":"37","author":"M Bartneck","year":"2015","unstructured":"Bartneck M, Scheyda KM, Warzecha KT, Rizzo LY, Hittatiya K, Luedde T, Storm G, Trautwein C, Lammers T, Tacke F (2015) Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases. Biomaterials 37:367\u2013382. doi: 10.1016\/j.biomaterials.2014.10.030","journal-title":"Biomaterials"},{"key":"3030_CR42","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/ncomms2282","volume":"3","author":"K Tang","year":"2012","unstructured":"Tang K, Zhang Y, Zhang H, Xu P, Liu J, Ma J, Lv M, Li D, Katirai F, Shen GX, Zhang G, Feng ZH, Ye D, Huang B (2012) Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun 3:1282. doi: 10.1038\/ncomms2282","journal-title":"Nat Commun"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3030-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:27:29Z","timestamp":1567790849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["3030"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3030-x","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]}}}